Cargando…
Aspirin enhances the therapeutic efficacy of cisplatin in oesophageal squamous cell carcinoma by inhibition of putative cancer stem cells
BACKGROUND: Cancer stem cells (CSCs) are related to the patient’s prognosis, recurrence and therapy resistance in oesophageal squamous cell carcinoma (ESCC). Although increasing evidence suggests that aspirin (acetylsalicylic acid, ASA) could lower the incidence and improve the prognosis of ESCC, th...
Autores principales: | Zou, Zhigeng, Zheng, Wei, Fan, Hongjun, Deng, Guodong, Lu, Shih-Hsin, Jiang, Wei, Yu, Xiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438052/ https://www.ncbi.nlm.nih.gov/pubmed/34316020 http://dx.doi.org/10.1038/s41416-021-01499-3 |
Ejemplares similares
-
Identification and characterization of stem cells in mammalian esophageal stratified squamous epithelia
por: Yang, Yanan, et al.
Publicado: (2022) -
Silencing of methyltransferase-like 3 inhibits oesophageal squamous cell carcinoma
por: Hu, Wen, et al.
Publicado: (2020) -
Aspirin overcomes cisplatin resistance in lung cancer by inhibiting cancer cell stemness
por: Zhao, Maoyuan, et al.
Publicado: (2020) -
The Cytotoxicity and Synergistic Potential of Aspirin and Aspirin
Analogues Towards Oesophageal and Colorectal Cancer
por: Kilari, Rajagopal S., et al.
Publicado: (2019) -
A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma
por: Wu, Mengjiao, et al.
Publicado: (2019)